SEC Form 4 · accession 0001472343-16-000132
Roka BioScience, Inc. · ROKA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Lars Boesgaard
Officer — Vice President, CFO
Period of report
Jan 4, 2016
Accepted (ET)
Jan 5, 2016 · 4:19 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001472343
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $1.13 | Jan 4, 2016 | A | 43,000 | A | Jan 4, 2017 | Jan 3, 2026 | Common Stock | 43,000 | 43,000 | D |
Explanation of responses
- F1Such stock options vest 25% on January 4, 2017 and in 1/36th increments on a monthly basis beginning one month after that. The stock options have a term of ten years.